Portfolio Companies News
June 17, 2021BONESUPPORT receives "breakthrough ...
Lund, Sweden, 10:00 CET, 17 06 21 BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company's antibiotic eluting product CERAMENT G has been categorized as a breakthrough device for the indication trauma by the US Food and Drug Admini... read more
June 17, 2021Targovax announces completed enroll...
The trial is now fully recruited with a total of 33 patients enrolled with 30 patients in the full dose ONCOS-102 and durvalumab combination in the colorectal cancer cohort Oslo, Norway, 17 June 2021 – Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing immune a... read more
June 16, 2021Aprea Therapeutics Announces Phase ...
37% CR rate in 30 efficacy-evaluable patients BOSTON, June 16, 2021 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protei... read more
June 14, 2021Fusion Pharmaceuticals Announces Pr...
Product candidate FPI-1434, administered at three different dose levels, demonstrated a favorable safety profile with no drug-related serious adverse events or dose-limiting toxicity Imaging shows drug uptake across multiple tumor types Enrollment in multi-dosing cohorts continues Fusion a... read more
June 14, 2021Targovax releases presentations of ...
Oslo, Norway, 14 June 2021 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, has released two video presentations related to the ONCOS-102 mesothelioma 24-month data. The 24-month follow-up data from the rand... read more
May 03, 2021Q1 2021 General Market Overview
Since the start in 1996, HealthCap funds have invested in 121 portfolio companies.
46 of the portfolio companies have been taken public on nine different markets.
27 of the portfolio companies pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 12 companies with a valuation of USD 1 billion or more.